Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix Cancer

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Carcinoma of the Appendix
			Colorectal Cancer
2		Additional conditions recognized in this trial
			Carcinoma
			Colorectal Neoplasms
3		More general conditions related to this trial
			Colonic Diseases
			Digestive System Diseases
			Digestive System Neoplasms
			Gastrointestinal Diseases
			Gastrointestinal Neoplasms
			Intestinal Diseases
			Intestinal Neoplasms
			Neoplasms
			Neoplasms by Histologic Type
			Neoplasms by Site
			Neoplasms, Glandular and Epithelial
			Rectal Diseases
4		Interventions listed in this trial
			thalidomide
			adjuvant therapy
5		More general drug interventions related to this trial
			Angiogenesis Inhibitors
			Angiogenesis Modulating Agents
			Anti-Bacterial Agents
			Anti-Infective Agents
			Antineoplastic Agents
			Growth Inhibitors
			Growth Substances
			Immunologic Factors
			Immunosuppressive Agents
			Leprostatic Agents
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
6		Sponsors listed in this trial
			Wake Forest University
			National Cancer Institute (NCI)